(firstQuint)Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients.

 This study will evaluate the efficacy and safety of intravenous (IV) iron (ferumoxytol) as compared to oral iron in the treatment of anemia in hemodialysis patients receiving erythropoietin.

 Patients are randomized to receive either two doses of 510 mg of intravenous ferumoxytol in sequential dialysis sessions or 200 mg oral elemental iron daily for three weeks.

.

 Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients@highlight

The study will evaluate the safety and efficacy of a new intravenously administered iron drug to treat anemia in patients on hemodialysis.

